Generic and biosimilar medicines saved U.S. patients $3.6 trillion in the last decade. Learn how this industry is driving America Forward as a force for healthcare stability and economic resilience.
Quick Links:
Generic and biosimilar medicines brought $496 billion in savings in 2025—and $3.6 trillion in savings in the last decade.
Join us at GRx+Biosims 2026 on November 2–4, for the leading regulatory, science and policy event in the U.S.
Desi’s journey from painful swelling to playing soccer again shows the power of accessible medicines.
Learn how a biosimilar medication helped Eileen stay focused on auditions, not Crohn’s disease.
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
